A detailed history of Geode Capital Management, LLC transactions in Liva Nova PLC stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,344,949 shares of LIVN stock, worth $62.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,344,949
Previous 1,336,618 0.62%
Holding current value
$62.9 Million
Previous $73.3 Million 3.62%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$43.38 - $54.59 $361,398 - $454,789
8,331 Added 0.62%
1,344,949 $70.6 Million
Q2 2024

Aug 09, 2024

BUY
$51.76 - $64.15 $3.3 Million - $4.1 Million
63,841 Added 5.02%
1,336,618 $73.3 Million
Q1 2024

May 13, 2024

BUY
$48.6 - $57.12 $2.32 Million - $2.73 Million
47,753 Added 3.9%
1,272,777 $71.2 Million
Q4 2023

Feb 13, 2024

BUY
$43.45 - $53.66 $2.16 Million - $2.67 Million
49,807 Added 4.24%
1,225,024 $63.4 Million
Q3 2023

Nov 13, 2023

BUY
$50.12 - $58.87 $2.49 Million - $2.93 Million
49,721 Added 4.42%
1,175,217 $62.1 Million
Q2 2023

Aug 11, 2023

BUY
$42.28 - $51.43 $2.76 Million - $3.36 Million
65,266 Added 6.16%
1,125,496 $57.9 Million
Q1 2023

May 15, 2023

BUY
$40.84 - $58.14 $2.11 Million - $3 Million
51,678 Added 5.12%
1,060,230 $46.2 Million
Q4 2022

Feb 13, 2023

BUY
$43.88 - $56.16 $1.41 Million - $1.8 Million
32,140 Added 3.29%
1,008,552 $56 Million
Q3 2022

Nov 14, 2022

BUY
$48.37 - $66.5 $909,791 - $1.25 Million
18,809 Added 1.96%
976,412 $49.6 Million
Q2 2022

Aug 12, 2022

SELL
$57.25 - $86.63 $120,969 - $183,049
-2,113 Reduced 0.22%
957,603 $59.8 Million
Q1 2022

May 13, 2022

BUY
$71.02 - $86.99 $1.51 Million - $1.85 Million
21,247 Added 2.26%
959,716 $78.5 Million
Q4 2021

Feb 11, 2022

BUY
$76.72 - $92.68 $1.89 Million - $2.28 Million
24,616 Added 2.69%
938,469 $82.1 Million
Q3 2021

Nov 12, 2021

BUY
$76.02 - $88.62 $4.31 Million - $5.02 Million
56,639 Added 6.61%
913,853 $72.4 Million
Q2 2021

Aug 13, 2021

BUY
$73.44 - $87.01 $2.37 Million - $2.81 Million
32,318 Added 3.92%
857,214 $72.1 Million
Q1 2021

May 12, 2021

BUY
$62.9 - $82.41 $3.63 Million - $4.76 Million
57,708 Added 7.52%
824,896 $60.8 Million
Q4 2020

Feb 12, 2021

BUY
$46.01 - $68.74 $2.17 Million - $3.25 Million
47,213 Added 6.56%
767,188 $50.8 Million
Q3 2020

Nov 13, 2020

SELL
$41.91 - $57.81 $781,663 - $1.08 Million
-18,651 Reduced 2.53%
719,975 $32.6 Million
Q2 2020

Aug 13, 2020

BUY
$39.87 - $56.9 $715,347 - $1.02 Million
17,942 Added 2.49%
738,626 $35.6 Million
Q1 2020

May 14, 2020

BUY
$34.22 - $76.49 $1.69 Million - $3.79 Million
49,511 Added 7.38%
720,684 $32.6 Million
Q4 2019

Feb 13, 2020

BUY
$68.92 - $85.27 $1.35 Million - $1.67 Million
19,543 Added 3.0%
671,173 $50.6 Million
Q3 2019

Nov 12, 2019

BUY
$71.74 - $86.35 $1.24 Million - $1.49 Million
17,215 Added 2.71%
651,630 $48.1 Million
Q2 2019

Aug 14, 2019

BUY
$66.45 - $97.36 $1.34 Million - $1.96 Million
20,122 Added 3.28%
634,415 $45.7 Million
Q1 2019

May 14, 2019

BUY
$86.15 - $100.49 $2.69 Million - $3.13 Million
31,193 Added 5.35%
614,293 $59.7 Million
Q4 2018

Feb 13, 2019

BUY
$84.14 - $125.42 $2.07 Million - $3.08 Million
24,561 Added 4.4%
583,100 $53.3 Million
Q3 2018

Nov 13, 2018

BUY
$101.02 - $130.95 $11.5 Million - $14.8 Million
113,349 Added 25.46%
558,539 $69.2 Million
Q2 2018

Aug 14, 2018

BUY
$81.75 - $105.37 $2.63 Million - $3.39 Million
32,203 Added 7.8%
445,190 $44.4 Million
Q1 2018

May 15, 2018

BUY
$79.95 - $89.74 $1.04 Million - $1.16 Million
12,953 Added 3.24%
412,987 $36.5 Million
Q4 2017

Feb 13, 2018

BUY
$71.8 - $88.21 $212,887 - $261,542
2,965 Added 0.75%
400,034 $32 Million
Q3 2017

Nov 14, 2017

SELL
$60.32 - $70.06 $3.31 Million - $3.85 Million
-54,909 Reduced 12.15%
397,069 $27.8 Million
Q2 2017

Aug 14, 2017

BUY
N/A
451,978
451,978 $27.7 Million

Others Institutions Holding LIVN

About LivaNova PLC


  • Ticker LIVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,545,700
  • Market Cap $2.5B
  • Description
  • LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...
More about LIVN
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.